Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
Phase 1 trial of olaparib and oral cyclophosphamide in <i>BRCA</i> breast cancer, recurrent <i>BRCA</i> ovarian cancer, non-<i>BRCA</i> triple-negative breast cancer, and non-BRCA ovarian cancer, Published online: 17 January 2019; doi:10.1038/s41416-018-0349-6
Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
https://go.nature.com/2QYbMcU
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.